Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

This document announces a Phase 4 clinical trial (SMART-VERAPAF) evaluating self-management and random therapy with verapamil or metoprolol in paroxysmal atrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL (METOPROLOL TARTRATE)
  • Verapamil (verapamil)

Snippet

Sponsor: Martini Hospital Groningen | Conditions: Atrial Fibrillation (AF) | Phase 4 | Status: NOT_YET_RECRUITING